GPX4 and chronic obstructive pulmonary disease: In a mouse model exposed to cigarettes, regarding the progression of resistance to COPD, with the exception of GPx4 knockdown, desferrioxamine and ferristatin-1 are a possible target for the treatment of ferroptosis-induced COPD (82).